Related Experiment Video
Updated: Jun 12, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Development and Dosimetric Characterization of an In Vitro Benchtop Americium 241 Alpha Irradiator Platform.
Sean P Jollota1, Sonja Dragojevic2, Nicholas B Remmes2
1Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Summary
Researchers developed a low-cost platform for in vitro alpha irradiation using Americium-241. This system is validated for high-throughput preclinical studies, offering stable and reliable dose rates for radiobiology research.
Area of Science:
- Radiation oncology
- Preclinical cancer research
- Radiobiology
Background:
- High linear energy transfer (LET) alpha particles offer unique radiobiological properties for cancer therapy.
- Robust, high-throughput in vitro platforms are essential for studying alpha particle radiobiology.
- Existing platforms require extensive characterization for reproducibility.
Purpose of the Study:
- To develop and characterize a benchtop in vitro alpha irradiation platform.
- To utilize Americium-241 (241Am) as a source for alpha particle irradiation.
- To enable high-throughput preclinical studies on alpha particle radiobiology.
Main Methods:
- A 241Am foil was used as the alpha source within a custom housing.
- A 3D-printed microcapillary array collimator narrowed the alpha particle energy spectrum and improved homogeneity.
- Dosimetric characterization included measurements of dose homogeneity, energy spectra, absorbed dose, and dose rate.
Main Results:
- The platform generated a spatially uniform and geometrically stable irradiation field.
- Mylar entrance window caused predictable shifts and broadening of alpha particle energy spectra.
- Measured dose rates ranged from 5.815 to 7.721 mGy/s, confirming feasibility.
Conclusions:
- A cost-effective, turnkey in vitro alpha irradiation platform was established for preclinical studies.
- The platform's performance, including dose and spectra, was validated through direct measurements.
- The long half-life of 241Am ensures stable dose rates for decades, supporting long-term radiobiological investigations.
